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Small leucine-rich proteoglycans of the cartilage and their 
potential role in tissue repair 
G. Cs-Szabo, United States of America 
The extracellular matrix (ECM) of the articular cartilage is composed 
of a variety of molecules synthesized by the chondrocytes. These 
NPMFDVMFT JODMVEF ¾CSJMGPSNJOH DPMMBHFOT MBSHF QSPUFPHMZDBOT
(PGs), such as aggrecan, and small leucine-rich PGs (SLRPs), such 
as biglycan and decorin. Chondrocytes also express cytokines 
and growth factors by which the cells respond to signal from the 
environment by changing the expression levels of the ECM molecules. 
It is believed that chondrocytes maintain homeostasis by balancing 
catabolic and anabolic events and thus, preserving the integrity of 
the ECM. Molecules that regulate the effects of growth factors and 
cytokines must be present in the matrix in order to balance their 
activities. Such regulatory molecules are known to be present in 
the ECM and they regulate matrix assembly and homeostasis by 
binding to matrix molecules or inhibiting growth factors, cytokines 
and enzymes. One of these molecules is believed to be the family of 
SLRPs. The structurally similar biglycan and decorin play regulatory 
roles in the assembly of the ECM by binding to different matrix 
NPMFDVMFTJODMVEJOH¾CSJMMBSDPMMBHFOT¾CSPOFDUJOBOEUIFNFNCFST
of the TGF-beta growth factor family. While decorin plays a key role 
JOSFHVMBUJOHDPMMBHFO¾CSJM GPSNBUJPOCJHMZDBOQMBZTBDSVDJBMSPMF
in the assembly of the pericellular matrix network. In osteoarthritis 
(OA), the delicate balance between catabolic and anabolic processes 
is broken, and the degradative processes are not well-balanced 
by repair attempts, resulting in massive loss of matrix molecules. 
We previously reported that the expression of both biglycan and 
decorin is increased in degenerated and OA cartilage. We have 
also shown that the expression of these SLRPs is upregulated by 
growth factor/cytokine effects (Il-1, IL-6, TGF-beta, and OP-1); their 
expression is either upregulated by the cytokine or increased after 
the removal of the cytokine. Thus, we propose that the increased 
expression of growth factors and the SLRPs is part of the attempt 
by the chondrocytes to repair the matrix. However, how decorin and 
biglycan is involved in the repair process is still to be determined. In 
this study, the potential consequences of the presence of elevated 
levels of decorin and biglycan, including their role in regulating 
growth factor effects and their direct effect on chondrocytes is 
determined. 
Human ankle joints from 20 donors with no known joint disease 
(age 65-75 years old) were received from the Gift of Hope Human 
Organ and Tissue Donor Network and used with the permission of 
the Institutional Review Board. All cartilages were normal by gross 
morphological examination (Collins Grade 0-1). Chondrocytes were 
released from the cartilages by sequential enzymatic digestion and 
DVMUVSFEJODPO¿VFOUNPOPMBZFSTPSFODBQTVMBUFEJOBMHJOBUFCFBET
Cell binding assays: Biglycan and decorin (Sigma) were labeled with 
Rhodamine-red (RR) according to the manufacturer’s instructions 
(Molecular Probes). Cells were cultured overnight in chamber 
slides, and then were subjected to RR-labeled biglycan or decorin 
at different concentrations for 30 min to 3 hr at 37°C. Fluorescent 
signal was observed with a Nikon Eclipse E600 microscope and 
images linked to a computer equipped with Metamorf software 
used for image analyzis. Competition assays were performed using 
RR-labeled biglycan or RR-labeled decorin in competition with non-
labeled biglycan, non-labeled decorin, epidermal growth factor (EGF, 
Sigma), EGF receptor blocking antibody (Sigma), or EGF receptor 
antagonist, Tyrphostin (Sigma). Fluorescent signal was observed 
with the Nikon Eclipse E600 microscope, listed above. For signaling 
studies, chondrocytes were cultured in monolayer and treated with 
different concentrations of biglycan or decorin between 10 minutes 
and 24 hours. Cells were also treated with EGF and inhibitors of 
several signaling pathways (Calbiochem). Cells were lyzed and 
signaling molecules as well as cyclin-dependent kinase inhibitors 
QBOEQXFSFEFUFDUFEVTJOHTQFDJ¾DBOUJCPEJFT	$FMM4JHOBMJOH

on Western blots. For gene expression studies, chondrocytes were 
cultured and treated as above for 2-24 hours. The cells were lyzed 
and total RNA was isolated. Expression levels of aggrecan, collagen 
type II, p21, p27, and certain matrix metalloproteinases (MMPs) 
were determined by RT/PCR using GAPDH as a control. Proteoglycan 
synthesis and accumulation in alginate bead cultures (24-96 h) 
were determined by sulfate incorporation and by DMMB assay, 
respectively, in the presence or absence of biglycan or decorin. Data 
were normalized to cell number determined by Picogreen DNA assay 
(Molecular Probes). Interaction of biglycan and decorin with growth 
factors was monitored by immunoprecipitation assays. Biglycan 
and decorin was incubated with TGF-beta or OP-1 (BMP-7) and the 
DPNQMFYXBTQSFDJQJUBUFEXJUITQFDJ¾DBOUJCPEJFTUP UIFTF4-31T
Western blot hybridization was used to detect the co-precipitated 
growth factors. ELISA assay was used to calculate the molecular 
ratio between small PGs and growth factors. Regulation of the effect 
of growth factors was achieved by treating chondrocytes, cultured 
in alginate beads, with biglycan, decorin, TGF-beta or OP-1 alone 
and with the combination of the small PGs with the growth factors. 
1SPUFPHMZDBOTZOUIFTJTBOEBDDVNVMBUJPOXBTRVBOUJ¾FE4UBUJTUJDBM
analyzes were performed by ANOVA. 
Chondrocytes express biglycan and decorin, and these molecules 
are deposited in the matrix. Although, both decorin and biglycan 
can be detected in both the pericellular and extracellular matrices, 
the majority of decorin is localized in the extracellular matrix on 
UIF DPMMBHFO ¾CFST XIJMF UIF NBKPSJUZ PG CJHMZDBO SFTJHOT JO UIF
pericellular matrix. In OA tissue, both SLRPs are expressed and 
accumulated in elevated amounts around the clusters formed 
by those cells that play active roles in the repair attempt. These 
newly synthesized biglycan and decorin molecules thus have the 
PQQPSUVOJUZUPJO¿VFODFUIFSFQBJSQSPDFTTBTXFMMBTUIFBDUJPOPG
growth factors. Our data showed that both biglycan and decorin 
was able to bind TGF-beta and OP-1 in an approximate 1:2 molar 
ratio. While both treatment with TGF-beta and OP-1 upregulated PG 
synthesis and resulted in an accumulation of PGs in alginate beads, 
the combination of these growth factors with biglycan or decorin 
abolished the anabolic effect of the growth factors. When biglycan 
or decorin were applied alone, these SLRPs exerted an inhibitory 
effect on PG synthesis and accumulation, thus these molecules have 
a direct effect on chondrocytes. When RR-labeled decorin or biglycan 
were applied in cell culture, these molecules were able to bind to the 
cells in a concentration- and time-dependent manner. Interestingly, 
biglycan completely abolished the binding of the RR-decorin 
and vice versa, thus both molecules bind to the same receptor. 
Competition of biglycan and decorin with the epidermal growth 
factor (EGF), an EGF receptor blocking antibody or Tyrphostin was 
concentration-dependent, and led to almost complete abolishment 
PGUIF¿VPSFTDFOUTJHOBM5IJTQSPWFTUIBUUIFNBKPSJUZPGCJHMZDBO
and decorin binds to these cells through the EGF receptor. Both 
biglycan and decorin was found to be signaling through the MAPK 
(ERK) and the PI3K (Akt) pathways, similar to EGF, the natural ligand 
PG UIF &('SFDFQUPS 4JHOBMT XFSF JOIJCJUFE CZ QBUIXBZTQFDJ¾D
inhibitors. Biglycan and decorin also activated p21 and p27, both 
factors known to promote cell cycle arrest. Treatment of the cells with 
FJUIFSCJHMZDBOPSEFDPSJO SFTVMUFE JOBTJHOJ¾DBOUEFDSFBTF JO UIF
expression levels of aggrecan and type II collagen. This goes parallel 
to the inhibition of PG synthetic rate and accumulation measured in 
alginate bead cultures. On the contrary, the message levels of MMP-
3 and -13 were upregulated. 
*O UIJT TUVEZXFEFNPOTUSBUF GPS UIF¾STU UJNF UIBU CJHMZDBO BOE
decorin may play an important role in regulating the effects of growth 
factors in cartilage. This effect can be exerted through growth factor 
CJOEJOHBOEBMTPUISPVHIEJSFDUCJOEJOHPGUIFTF4-31TUPTQFDJ¾D
cell surface receptors of chondrocytes. Receptor binding can 
UIFO SFTVMU JO UIFBDUJWBUJPOPG TQFDJ¾D JOUSBDFMMVMBSQBUIXBZTBOE
regulation of certain gene expression levels. The major receptor for 
biglycan and decorin is most likely the EGF receptor, and the MAPK 
(ERK) and PI3K (Akt) pathways are the ones that are activated by 
CPUITNBMM1(T"DDPSEJOHUPPVS¾OEJOHTXIFOCJHMZDBOBOEEFDPSJO
are used in combination with growth factors, the anabolic effect of 
these factors on PG synthesis is abrogated. In turn, the binding of 
decorin or biglycan to the EGF receptor results in downregulation 
of the expression levels of the aggrecan and collagen type II genes. 
This in turn, results in reducing matrix deposition around the cells. 
This may imply that these SLRPs, which are upregulated by TGF-ȕ
and OP-1, may serve as regulators of the effects of growth factors 
by imposing an opposite effect on the expression levels of the major 
ECM molecules. The ability of the SLRPs to upregulate MMP-3 and 
MMP-13 suggests not only an anti-anabolic but also a catabolic role 
for this molecule. This, again, is an opposite of the effect of growth 
factors on these enzymes. The upregulation by biglycan and decorin 
of cell cycle inhibitors p21 and p27 that inhibit cell proliferation may 
additionally counteract the effect of growth factors. In summary, 
these results suggest that the presence of increased amounts of 
biglycan or decorin in OA cartilage may interfere with the repair 
process by negatively regulating the effect of growth factors on 
matrix deposition and cell proliferation. This role of these SLRPs 
may be very important in normal homeostasis to allow cells to work 
within a regulated environment. In OA cartilage, where the loss of 
matrix is extensive, this regulatory effect may also be important for 
a certain extent, but it also may contribute to the inability of growth 
factors to repair the matrix properly. 
